Overview

Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of two shortened regimens for newly diagnosed smear positive drug susceptible pulmonary tuberculosis in comparison to World Health Organization recommended standard 6-month regimen.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Chest Hospital
Collaborators:
Anhui Chest Hospital
Beijing Research Institute for Tuberculosis Control
Centers for Disease Control and Prevention, China
Centre for Tuberculosis Control of Guangdong Province
Changchun Infectious Disease Hospital
Changsha Central Hospital
Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC
China Shenyang Chest Hospital
Chongqing Infectious Disease Medical Center
Dalian Tuberculosis Hospital
First Affiliated Hospital of Xinjiang Medical University
Fouzhou Pulmonary Hospital of Fujian
Guangxi Center for Disease Prevention and Control
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
Guiyang Public Health Clinical Center
Handan Infectious Disease Hospital
Harbin Chest Hospital
Hebei Chest Hospital
Heilongjiang Province center for tuberculosis Control and Prevention
Hubei Provincial Center for Disease Control and Prevention
Hunan Institute For Tuberculosis Control
Infectious Disease Prevention Hospital in Heilongjiang Province
Jiamusi City Tumour Hospital
Jiangxi Chest Hospital
Kaifeng Central Hospital
Kaifeng Pulmonary Disease Hospital
Mudanjiang City Hospital of Infectious Disease
Public Health Clinical Center of Chengdu
Pulmonary Hospital of Lanzhou
Qingdao Chest Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Shenyang Chest Hospital
Shenzhen Third Peple's Hospital
Sixth People's Hospital of Nanyang City
Taiyuan Fourth People's Hospital
The 4th People's Hospital of Qinghai Province
The Fifth People's Hospital of Suzhou
The First Affiliated Hospital of Xiamen University
The First Affiliated Hospital of Xinxiang Medical University
The First Affiliated Hospital with Nanjing Medical University
The Fourth People's Hospital of Ningxia Autonomous Region
The Hospital Group of the First Affiliated Hospital of CQMU
The Infectious Disease Hospital of Wangkai Zaozhuang
The Infectious Hospital of Hebi
The Sixth People's Hospital of Nantong
The Sixth Peple's Hosptal of Zhengzhou
The Third People's Hospital of Kunming City
The Third People's Hospital of Zhenjiang
The Tuberculosis Prevention and Treatment Hospital of Shanxi Province
Tianjin centers for Disease Control and Prevention
Tianjin Haihe Hospital
Tuberculosis Hospital in Jilin Province
Wuhan Institute for Tuberculosis Control
Wuhan Union Hospital, China
Xi'an Chest Hospital
Treatments:
Ethambutol
Isoniazid
Levofloxacin
Ofloxacin
Pyrazinamide
Rifampin